Literature DB >> 1409363

Cholesterol (thermodynamic) activity determinations in bile salt-lecithin-cholesterol systems and cholesterol-rich liquid crystalline mesophase formation.

U K Jain1, W I Higuchi, C L Liu, P H Lee, N A Mazer.   

Abstract

Previous in vitro studies have shown that tauroursodeoxycholate (TUDC)-lecithin (L) micellar solutions solubilize cholesterol (Ch) poorly compared to its 7 alpha-epimer, taurochenodeoxycholate (TCDC). However, in clinical studies ursodeoxycholic acid (UDC) has been found to be as effective as chenodeoxycholic acid (CDC) in Ch gallstone dissolution, and it has been suggested that, during UDC therapy, liquid crystalline mesophase formation may be involved in enhancing micellar Ch dissolution and dispersion. The purpose of the present study was to investigate whether measurements of the Ch thermodynamic activity (A(T) would provide new insights into the problem of Ch solubilization and mesophase formation in bile salt-lecithin-Ch systems. Using the silicone polymer uptake method developed in this laboratory, A(T) was measured as a function of Ch concentration in the TUDC-L-Ch and TCDC-L-Ch model bile systems. In the TCDC systems Henry's law was obeyed almost up to unit activity (i.e., A(T) was proportional to Ch concentration almost up to A(T) = 1.0). However, in many of the TUDC-containing systems negative deviations from Henry's law were observed well below unit activity and these systems became visibly turbid before saturation with respect to cholesterol monohydrate (ChM) was reached. The effects of varying the TCDC/TUDC ratio upon the A(T) behavior were also studied. With increasing TCDC/TUDC ratio, the onset of mesophase formation was shifted to higher A(T) values. A(T) measurements were also conducted in BS-L-Ch mixtures simulating biles of patients undergoing UDC therapy. The results obtained suggest that mesophase formation may not always occur in biles of patients undergoing UDC therapy.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1409363     DOI: 10.1023/a:1015811807438

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  25 in total

1.  Proceedings of the workshop on Frontiers in Gallstone Formation. Biliary cholesterol transport and precipitation. Warrenton, Virginia. April 16-19, 1989.

Authors: 
Journal:  Hepatology       Date:  1990-09       Impact factor: 17.425

2.  Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. part I.

Authors:  W H Bachrach; A F Hofmann
Journal:  Dig Dis Sci       Date:  1982-08       Impact factor: 3.199

3.  Cholesterol gallstone dissolution in bile: dissolution kinetics of crystalline (anhydrate and monohydrate) cholesterol with chenodeoxycholate, ursodeoxycholate, and their glycine and taurine conjugates.

Authors:  H Igimi; M C Carey
Journal:  J Lipid Res       Date:  1981-02       Impact factor: 5.922

4.  Mesophase formation during in vitro cholesterol gallstone dissolution: a specific effect of ursodeoxycholic acid.

Authors:  C C Su; J Y Park; W I Higuchi; M H Alkan; O I Corrigan; A F Hofmann; R G Danzinger
Journal:  J Pharm Sci       Date:  1981-06       Impact factor: 3.534

5.  The physical chemistry of cholesterol solubility in bile. Relationship to gallstone formation and dissolution in man.

Authors:  M C Carey; D M Small
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

6.  Changes in biliary lipid and biliary bile acid composition in patients after administration of ursodeoxycholic acid.

Authors:  I Makino; S Nakagawa
Journal:  J Lipid Res       Date:  1978-08       Impact factor: 5.922

7.  Silicone polymer uptake method for determination of cholesterol thermodynamic activity in model bile systems.

Authors:  P H Lee; D C Cheng; K Takayama; W I Higuchi
Journal:  J Pharm Sci       Date:  1988-07       Impact factor: 3.534

8.  Efficacy and indications of ursodeoxycholic acid treatment for dissolving gallstones. A multicenter double-blind trial. Tokyo Cooperative Gallstone Study Group.

Authors: 
Journal:  Gastroenterology       Date:  1980-03       Impact factor: 22.682

9.  Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short erm feeding of chenodeoxycholic and ursodeoxycholic acid.

Authors:  N Carulli; M Ponz De Leon; F Zironi; A Pinetti; A Smerieri; R Iori; P Loria
Journal:  J Lipid Res       Date:  1980-01       Impact factor: 5.922

10.  Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone.

Authors:  M Podda; M Zuin; P M Battezzati; C Ghezzi; C de Fazio; M L Dioguardi
Journal:  Gastroenterology       Date:  1989-01       Impact factor: 22.682

View more
  1 in total

1.  The influence of water content of triglyceride oils on the solubility of steroids.

Authors:  Laura M Land; Ping Li; Paul Michael Bummer
Journal:  Pharm Res       Date:  2005-05-17       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.